Dyne Therapeutics logo

Dyne Therapeutics share price today

(DYN)

Dyne Therapeutics share price is $23.99 & ₹2,038.57 as on 21 Dec 2024, 2.30 'hrs' IST

$23.99

▲

-0.31

(-1.28%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Dyne Therapeutics share price in Dollar and Rupees. Guide to invest in Dyne Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Dyne Therapeutics. Get details on the Indian mutual funds that are investing in Dyne Therapeutics. Get Analyst recommendations and forecasts along with all the Dyne Therapeutics's financials.

Dyne Therapeutics share price movements

  • Today's Low: $23.65
    Today's High: $24.90

    Day's Volatility :5.02%

  • 52 Weeks Low: $12.06
    52 Weeks High: $47.45

    52 Weeks Volatility :74.58%

Dyne Therapeutics Returns

PeriodDyne Therapeutics, IncSector (Health Care)Index (Russel 2000)
3 Months
-30.72%
-11.1%
0.0%
6 Months
-32.67%
-6.0%
0.0%
1 Year
89.64%
2.7%
0.0%
3 Years
85.97%
0.6%
-19.7%

Dyne Therapeutics Key Statistics

in dollars & INR

Previous Close
$24.3
Open
$23.91
Today's High
$24.9
Today's Low
$23.65
Market Capitalization
$2.4B
Today's Volume
$1.4M
52 Week High
$47.45
52 Week Low
$12.06
Revenue TTM
$0.0
EBITDA
$-312.8M
Earnings Per Share (EPS)
$-3.58
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-68.68%

How to invest in Dyne Therapeutics from India?

It is very easy for Indian residents to invest directly in Dyne Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Dyne Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Dyne Therapeutics or DYN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Dyne Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Dyne Therapeutics shares which would translate to 0.035 fractional shares of Dyne Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Dyne Therapeutics, in just a few clicks!

Returns in Dyne Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Dyne Therapeutics investment value today

Current value as on today

₹1,91,840

Returns

₹91,840

(+91.84%)

Returns from Dyne Therapeutics Stock

₹89,644 (+89.64%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Dyne Therapeutics

-29%

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Search volume for Dyne Therapeutics on INDmoney from India has reduced in the last 30 days as on Dec 22, 2024. -29% less investors are searching Dyne Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Dyne Therapeutics

  • FMR Inc

    8.87%

  • BlackRock Inc

    7.26%

  • Vanguard Group Inc

    6.75%

  • RTW INVESTMENTS, LLC

    6.70%

  • HHG PLC

    6.69%

  • RA Capital Management, LLC

    6.27%

Analyst Recommendation on Dyne Therapeutics

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Dyne Therapeutics(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
12
11
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Dyne Therapeutics

What analysts predicted

Upside of 110.16%

Current:

$23.99

Target:

$50.42

Insights on Dyne Therapeutics

  • Price Movement

    In the last 1 month, DYN stock has moved down by -19.3%

Dyne Therapeutics Technicals Summary

Sell

Neutral

Buy

Dyne Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Dyne Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Dyne Therapeutics, Inc
Dyne Therapeutics, Inc
-19.2%
-32.67%
89.64%
85.97%
0.38%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.38%
12.23%
86.41%
Biontech Se
Biontech Se
4.48%
30.56%
7.97%
-55.71%
237.85%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.37%
26.29%
108.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-2.55%
77.79%
80.12%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Dyne Therapeutics, Inc
Dyne Therapeutics, Inc
NA
NA
0.19
-3.46
-0.69
-0.4
NA
6.93
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Dyne Therapeutics, Inc
Dyne Therapeutics, Inc
Buy
$2.4B
0.38%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
86.41%
17.51
33.61%
Biontech Se
Biontech Se
Buy
$26.7B
237.85%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
108.55%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.12%
32.84
-4.51%

Dyne Therapeutics Dividend announcements

  • Dyne Therapeutics Earnings

    Dyne Therapeutics’s price-to-earnings ratio stands at None

    Read More

About Dyne Therapeutics

dyne therapeutics, inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the united states. it develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its force platform that delivers disease-modifying therapies. the company was founded in 2017 and is based in waltham, massachusetts.
Organization
Dyne Therapeutics
Employees
173
CEO
Mr. John G. Cox M.B.A.
Industry
Commercial Services

Management People of Dyne Therapeutics

NameTitle
Mr. John G. Cox M.B.A.
CEO, President & Director
Dr. Romesh Subramanian Ph.D.
Co-Founder & Advisor
Mr. Richard William Scalzo M.B.A.
Senior VP and Head of Finance & Administration
Mr. John Najim M.B.A.
Chief Technical Officer
Dr. Oxana Beskrovnaya Ph.D.
Chief Scientific Officer
Ms. Amy Reilly
Senior VP and Head of Corporate Communications & Investor Relations
Mr. Daniel Wilson
Senior VP & Head of Legal
Ms. Lucia Celona
Chief Human Resource Officer
Ms. Debra Feldman
Chief Regulatory Affairs Officer
Dr. Ashish Dugar M.B.A., Ph.D.
Chief Medical Affairs Officer

Important FAQs about investing in Dyne Therapeutics from India :

What is Dyne Therapeutics share price today?

Dyne Therapeutics share price today stands at $23.99, Open: $23.91 ; Previous Close: $24.30 ; High: $24.90 ; Low: $23.65 ; 52 Week High: $47.45 ; 52 Week Low: $12.06. The stock opens at $23.91, after a previous close of $24.30. The stock reached a daily high of $24.90 and a low of $23.65, with a 52-week high of $47.45 and a 52-week low of $12.06.

Can Indians buy Dyne Therapeutics shares?

Yes, Indians can invest in the Dyne Therapeutics (DYN) from India.

With INDmoney, you can buy Dyne Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Dyne Therapeutics at zero transaction cost.

How can I buy Dyne Therapeutics shares from India?

It is very easy to buy Dyne Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Dyne Therapeutics be purchased?

Yes, you can buy fractional shares of Dyne Therapeutics with INDmoney app.

What are the documents required to start investing in Dyne Therapeutics stocks?

To start investing in Dyne Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Dyne Therapeutics

Today’s highest price of Dyne Therapeutics (DYN) is $24.90.

Today’s lowest price of Dyne Therapeutics (DYN) is $23.65.

What is today's market capitalisation of Dyne Therapeutics

Today's market capitalisation of Dyne Therapeutics DYN is 2.4B

What is the 52 Week High and Low Range of Dyne Therapeutics

  • 52 Week High

    $47.45

  • 52 Week Low

    $12.06

What are the historical returns of Dyne Therapeutics?

  • 1 Month Returns

    -19.2%

  • 3 Months Returns

    -32.67%

  • 1 Year Returns

    89.64%

  • 5 Years Returns

    0.38%

Who is the Chief Executive Officer (CEO) of Dyne Therapeutics

Mr. John G. Cox M.B.A. is the current Chief Executive Officer (CEO) of Dyne Therapeutics.